Purpose: To evaluate mini-sling long-term results and correlate them to failure predictors. Many studies show comparable results among different single-incision slings developed as an attempt to reduce complications while keeping good results, but there is a lack of evidence about mini-slings outcomes in the long term. Methods: This prospective, single-center study evaluated 40 patients for long-term outcomes after mini-sling placement. Objective cure was defined as leakage of less than 1 g in 1-hour pad-test and no leakage at Valsalva maneuver. An objective improvement was defined as leakage of a maximum 50% of the preoperative test. Subjective continence was considered as a zero score at International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Patients were also evaluated for comorbidities and previous surgeries. Results: The mean age was 56 (±9.3) years, the mean ICIQ-SF score was 16 (±2.98) before surgery and 3.5 (± 5) at last follow-up, showing sustained improvement in the long term, mean 100 (84–109) months follow-up. The objective results show 67.5% of success, 17.5% of improvement, and 15% of failure. Age and parity were not related to outcomes (p = 0.33), but previous surgeries increase failure rate with 5.66 OR (p = 0.04). Success, improvement, and failure rates were 85, 10, and 5% for treatment-naive patients versus 50, 25, and 25% for patients with previous surgeries, respectively. Conclusion: Mini-sling Ophira shows good long-term results with low complications rates in patients without previous anti-incontinence surgery. Randomized trials are necessary to compare mini-slings results to other mid-urethral slings in recurred stress urinary incontinence.

Keywords:
Mini-sling, Incontinence, Treatment, Long term
1.
Ford AA, Rogerson L, Cody JD, Ogah J. Mid-urethral sling operations for stress urinary incontinence in women.
Cochrane Database Syst Rev
. 2015 Jul;(7):CD006375.
2.
Aydın S, Arıoğlu Aydın Ç. Effect of concomitant single incision vaginal surgery on mid urethral sling success.
Neurourol Urodyn
. 2016 Nov; 35(8): 995–9.
3.
Abrams P, Blaivas JG, Stanton SL, Andersen JT; The International Continence Society Committee on Standardisation of Terminology. The standardisation of terminology of lower urinary tract function.
Scand J Urol Nephrol Suppl
. 1988; 114(5): 5–19.
4.
Barber MD, Weidner AC, Sokol AI, Amundsen CL, Jelovsek JE, Karram MM, et al.; Foundation for Female Health Awareness Research Network. Single-incision mini-sling compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial.
Obstet Gynecol
. 2012 Feb; 119(2 Pt 1): 328–37.
5.
Abdel-Fattah M, Agur W, Abdel-All M, Guerrero K, Allam M, Mackintosh A, et al. Prospective multi-centre study of adjustable single-incision mini-sling (Ajust(®) ) in the management of stress urinary incontinence in women: 1-year follow-up study.
BJU Int
. 2012 Mar; 109(6): 880–6.
6.
Mostafa A, Agur W, Abdel-All M, Guerrero K, Lim C, Allam M, et al. Multicenter prospective randomized study of single-incision mini-sling vs tension-free vaginal tape-obturator in management of female stress urinary incontinence: a minimum of 1-year follow-up.
Urology
. 2013 Sep; 82(3): 552–9.
7.
Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence.
Int Urogynecol J Pelvic Floor Dysfunct
. 2008 Aug; 19(8): 1043–7.
8.
Palma P, Riccetto C, Bronzatto E, Castro R, Altuna S. What is the best indication for single-incision Ophira Mini Sling? Insights from a 2-year follow-up international multicentric study.
Int Urogynecol J Pelvic Floor Dysfunct
. 2014 May; 25(5): 637–43.
9.
Rosier PF, Schaefer W, Lose G, Goldman HB, Guralnick M, Eustice S, et al. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study.
Neurourol Urodyn
. 2017 Jun; 36(5): 1243–60.
10.
Tamanini JT, Dambros M, D’Ancona CA, Palma PC, Rodrigues Netto N Jr. [Validation of the “International Consultation on Incontinence Questionnaire— short Form” (ICIQ-SF) for Portuguese].
Rev Saude Publica
. 2004 Jun; 38(3): 438–44.
11.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience.
Ann Surg
. 2009 Aug; 250(2): 187–96.
12.
Al-Zahrani AA, Gajewski J. Long-term patient satisfaction after retropubic and transobturator mid-urethral slings for female stress urinary incontinence.
J Obstet Gynaecol Res
. 2016 Sep; 42(9): 1180–5.
13.
Mostafa A, Lim CP, Hopper L, Madhuvrata P, Abdel-Fattah M. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications.
Eur Urol
. 2014 Feb; 65(2): 402–27.
14.
Cornu JN, Lizée D, Sèbe P, Peyrat L, Ciofu C, Cussenot O, et al. TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken.
Eur Urol
. 2012 Oct; 62(4): 737–8.
15.
Naumann G, Albrich S, Skala C, Laterza R, Kölbl H. Single-Incision Slings (SIS) - a New Option for the Surgical Treatment of Female Stress Urinary Incontinence.
Geburtshilfe Frauenheilkd
. 2012 Feb; 72(2): 125–31.
16.
Siniscalchi RT, Melo M, Palma PC, Dal Fabbro IM, Vidal BC, Riccetto CL. Highly purified collagen coating enhances tissue adherence and integration properties of monofilament polypropylene meshes.
Int Urogynecol J Pelvic Floor Dysfunct
. 2013 Oct; 24(10): 1747–54.
17.
Liapis A, Bakas P, Creatsas G. Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: efficacy at 5- and 7-year follow-up.
Int Urogynecol J Pelvic Floor Dysfunct
. 2008 Nov; 19(11): 1509–12.
18.
Meschia M, Pifarotti P, Gattei U, Bertozzi R. Tension-free vaginal tape: analysis of risk factors for failures.
Int Urogynecol J Pelvic Floor Dysfunct
. 2007 Apr; 18(4): 419–22.
19.
Bergman A, Koonings PP, Ballard CA. Negative Q-tip test as a risk factor for failed incontinence surgery in women.
J Reprod Med
. 1989 Mar; 34(3): 193–7.
20.
Liapis A, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape.
Eur Urol
. 2009 Jun; 55(6): 1450–5.
21.
de Vries AM, van Breda HM, Fernandes JG, Venema PL, Heesakkers JP. Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and Safety.
Urol Int
. 2017; 99(1): 91–7.
22.
Pereira E Silva R, Gomes Olival V, Ponte C, Palma Dos Reis J, Colaço J, Grilo I, et al. Overactive Bladder Symptoms after Transobturator Sling Surgery for Pure Stress Urinary Incontinence: A Cross-Sectional Comparative Study.
Urol Int
. 2018; 100(4): 428–33.
23.
Agur W, Riad M, Secco S, Litman H, Madhuvrata P, Novara G, et al. Surgical treatment of recurrent stress urinary incontinence in women: a systematic review and meta-analysis of randomised controlled trials.
Eur Urol
. 2013 Aug; 64(2): 323–36.
24.
Stav K, Dwyer PL, Rosamilia A, Schierlitz L, Lim YN, Chao F, et al. Repeat synthetic mid urethral sling procedure for women with recurrent stress urinary incontinence.
J Urol
. 2010 Jan; 183(1): 241–6.
25.
Verbrugghe A, De Ridder D, Van der Aa F. A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence.
Int Urogynecol J Pelvic Floor Dysfunct
. 2013 Jun; 24(6): 999–1004.
26.
Tommaselli GA, Di Carlo C, Formisano C, Fabozzi A, Nappi C. Medium-term and long-term outcomes following placement of midurethral slings for stress urinary incontinence: a systematic review and metaanalysis.
Int Urogynecol J Pelvic Floor Dysfunct
. 2015 Sep; 26(9): 1253–68.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.